PlainRecalls
FDA Drug Low Class III Terminated

Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com

Reported: March 13, 2024 Initiated: February 9, 2024 #D-0367-2024

Product Description

Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com

Reason for Recall

Failed Dissolution Specifications: results slightly under spec at at 9-months.

Details

Units Affected
54, 131 bottles
Distribution
USA Nationwide
Location
Irvine, CA

Frequently Asked Questions

What product was recalled?
Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com. Recalled by Stason Pharmaceuticals, Inc.. Units affected: 54, 131 bottles.
Why was this product recalled?
Failed Dissolution Specifications: results slightly under spec at at 9-months.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 13, 2024. Severity: Low. Recall number: D-0367-2024.